Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure.

MLA

Schechter, Matthew A., et al. “Phosphoproteomic Profiling of Human Myocardial Tissues Distinguishes Ischemic from Non-Ischemic End Stage Heart Failure.” PloS One, vol. 9, no. 8, Aug. 2014, p. e104157. EBSCOhost, https://doi.org/10.1371/journal.pone.0104157.

APA

Schechter, M. A., Hsieh, M. K. H., Njoroge, L. W., Thompson, J. W., Soderblom, E. J., Feger, B. J., Troupes, C. D., Hershberger, K. A., Ilkayeva, O. R., Nagel, W. L., Landinez, G. P., Shah, K. M., Burns, V. A., Santacruz, L., Hirschey, M. D., Foster, M. W., Milano, C. A., Moseley, M. A., Piacentino, V., 3rd, & Bowles, D. E. (2014). Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure. PloS One, 9(8), e104157. https://doi.org/10.1371/journal.pone.0104157

Chicago

Schechter, Matthew A, Michael K H Hsieh, Linda W Njoroge, J Will Thompson, Erik J Soderblom, Bryan J Feger, Constantine D Troupes, et al. 2014. “Phosphoproteomic Profiling of Human Myocardial Tissues Distinguishes Ischemic from Non-Ischemic End Stage Heart Failure.” PloS One 9 (8): e104157. doi:10.1371/journal.pone.0104157.